The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era
The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by th...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-09-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.976143/full |
| _version_ | 1818050855242301440 |
|---|---|
| author | Zheng Li Zheng Li Yue Hu Ming Zeng Qinyong Hu Fei Ye Ruifeng Liu Ruifeng Liu Hongyi Cai Qiang Li Qiang Li Xiaohu Wang Xiaohu Wang |
| author_facet | Zheng Li Zheng Li Yue Hu Ming Zeng Qinyong Hu Fei Ye Ruifeng Liu Ruifeng Liu Hongyi Cai Qiang Li Qiang Li Xiaohu Wang Xiaohu Wang |
| author_sort | Zheng Li |
| collection | DOAJ |
| description | The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile. |
| first_indexed | 2024-12-10T11:00:06Z |
| format | Article |
| id | doaj.art-ca81bd3737f24c3aaf66e807a5e4259b |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-10T11:00:06Z |
| publishDate | 2022-09-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-ca81bd3737f24c3aaf66e807a5e4259b2022-12-22T01:51:44ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-09-011210.3389/fonc.2022.976143976143The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 eraZheng Li0Zheng Li1Yue Hu2Ming Zeng3Qinyong Hu4Fei Ye5Ruifeng Liu6Ruifeng Liu7Hongyi Cai8Qiang Li9Qiang Li10Xiaohu Wang11Xiaohu Wang12Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaLanzhou Heavy Ion Hospital, Lanzhou, ChinaChengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Radiation Oncology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, United StatesCancer Center, Renmin Hospital of Wuhan University, Wuhan, ChinaInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaLanzhou Heavy Ion Hospital, Lanzhou, ChinaDepartment of Radiotherapy, Gansu Provincial Hospital, Lanzhou, ChinaInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaLanzhou Heavy Ion Hospital, Lanzhou, ChinaInstitute of Modern Physics, Chinese Academy of Sciences, Lanzhou, ChinaLanzhou Heavy Ion Hospital, Lanzhou, ChinaThe uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.https://www.frontiersin.org/articles/10.3389/fonc.2022.976143/fullCOVID-19SARS-CoV-2liver neoplasmsradiotherapyartificial intelligencetelemedicine |
| spellingShingle | Zheng Li Zheng Li Yue Hu Ming Zeng Qinyong Hu Fei Ye Ruifeng Liu Ruifeng Liu Hongyi Cai Qiang Li Qiang Li Xiaohu Wang Xiaohu Wang The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era Frontiers in Oncology COVID-19 SARS-CoV-2 liver neoplasms radiotherapy artificial intelligence telemedicine |
| title | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
| title_full | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
| title_fullStr | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
| title_full_unstemmed | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
| title_short | The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era |
| title_sort | role transition of radiotherapy for the treatment of liver cancer in the covid 19 era |
| topic | COVID-19 SARS-CoV-2 liver neoplasms radiotherapy artificial intelligence telemedicine |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.976143/full |
| work_keys_str_mv | AT zhengli theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT zhengli theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT yuehu theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT mingzeng theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT qinyonghu theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT feiye theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT ruifengliu theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT ruifengliu theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT hongyicai theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT qiangli theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT qiangli theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT xiaohuwang theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT xiaohuwang theroletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT zhengli roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT zhengli roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT yuehu roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT mingzeng roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT qinyonghu roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT feiye roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT ruifengliu roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT ruifengliu roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT hongyicai roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT qiangli roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT qiangli roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT xiaohuwang roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era AT xiaohuwang roletransitionofradiotherapyforthetreatmentoflivercancerinthecovid19era |